---
title: "Pharma Grade Aluminum Chloride Hexahydrate Market, Global Outlook and Forecast 2025-2032"
datePublished: Thu Aug 14 2025 21:14:12 GMT+0000 (Coordinated Universal Time)
cuid: cmebwd5g1000202jv7fjq1huk
slug: pharma-grade-aluminum-chloride-hexahydrate-market-global-outlook-and-forecast-2025-2032

---

# Pharma Grade Aluminum Chloride Hexahydrate Market, Global Outlook and Forecast 2025-2032

<p><strong>MARKET INSIGHTS</strong></p><p>
</p><p>Global Pharma Grade Aluminum Chloride Hexahydrate market size was valued at USD 167 million in 2024. The market is projected to grow from USD 178 million in 2025 to USD 241 million by 2032, exhibiting a CAGR of 5.2% during the forecast period.</p><div><b>Download FREE Sample of this Report @ 
            <a href="https://www.24chemicalresearch.com/download-sample/296633/pharma-grade-aluminum-chloride-hexahydrate-market">
            https://www.24chemicalresearch.com/download-sample/296633/pharma-grade-aluminum-chloride-hexahydrate-market</a></b></div><br><p>
</p><p>Pharma Grade Aluminum Chloride Hexahydrate is a high-purity chemical compound primarily used in pharmaceutical applications due to its astringent, antiperspirant, and antimicrobial properties. It plays a critical role in medical formulations for treating conditions like hyperhidrosis (excessive sweating) and minor bleeding, while also finding applications in dermatological treatments.</p><p>
</p><p>The market growth is driven by increasing healthcare expenditure, which reached USD 1475 billion globally in 2022, and rising demand for specialized pharmaceutical ingredients. However, stringent regulatory requirements for pharmaceutical-grade materials and competition from alternative compounds present challenges. Key manufacturers including BASF, Kemira, and Aditya Birla Chemicals are investing in production capacity expansion to meet the growing demand from both pharmaceutical and cosmetic sectors.</p><p>
<strong>MARKET DYNAMICS</strong></p><p>
<strong>MARKET DRIVERS</strong></p><p>
</p><p style="text-align:center"><strong>Rising Prevalence of Hyperhidrosis to Accelerate Market Expansion</strong></p><p>
</p><p>The global pharma grade aluminum chloride hexahydrate market is witnessing significant growth due to the increasing incidence of hyperhidrosis (excessive sweating). Recent epidemiological studies indicate that approximately 4.8% of the U.S. population suffers from this condition, with similar prevalence rates observed in developed markets worldwide. As aluminum chloride hexahydrate remains the first-line topical treatment for primary axillary hyperhidrosis, its demand continues to surge. The compound's effectiveness in blocking sweat ducts through protein precipitation makes it indispensable in dermatological formulations. Moreover, growing patient awareness about treatment options and improved healthcare access in emerging economies are further propelling market growth.</p><p>
</p><p style="text-align:center"><strong>Pharmaceutical Industry Growth to Stimulate Product Demand</strong></p><p>
</p><p>The expansion of the global pharmaceutical sector, valued at approximately $1.48 trillion in 2023, creates substantial opportunities for pharmaceutical excipients and active ingredients. Aluminum chloride hexahydrate plays multiple roles in drug formulations â as an astringent in antihemorrhoidal preparations, an antiperspirant active, and a catalyst in synthesis processes. With the pharmaceutical excipients market projected to grow at 6.1% CAGR through 2030, the demand for high-purity aluminum chloride hexahydrate is expected to rise proportionally. Additionally, the compound's application in niche therapeutic areas like wound care and hemostasis contributes to steady market growth.</p><p>
</p><p style="text-align:center"><strong>Cosmetic Industry Innovations Drive Formulation Needs</strong></p><p>
</p><p>The personal care industry's increasing focus on advanced antiperspirant technologies represents a key growth driver. Modern cosmetic formulations now incorporate aluminum chloride hexahydrate in various concentrations (typically 15-25%) to provide long-lasting sweat protection. The global antiperspirant market, valued at over $75 billion, continues to expand as consumer expectations evolve toward clinical-strength solutions. Leading brands are investing heavily in research to develop more effective and skin-friendly formulations, with aluminum chloride remaining the gold standard active ingredient. This sustained demand from the beauty and personal care sector ensures a stable revenue stream for pharma-grade suppliers.</p><p>
<strong>MARKET RESTRAINTS</strong></p><p>
</p><p style="text-align:center"><strong>Stringent Regulatory Requirements Impede Market Growth</strong></p><p>
</p><p>The pharmaceutical-grade aluminum chloride hexahydrate market faces significant constraints due to rigorous quality and safety regulations. Compliance with pharmacopeial standards (USP, EP, JP) requires extensive testing and documentation, increasing production costs by 15-20% compared to industrial grade material. Regulatory agencies have implemented strict limits on aluminum content in medications due to potential neurotoxicity concerns, particularly for injectable formulations. These constraints limit the compound's applications in certain therapeutic areas and require manufacturers to maintain exceptional quality control measures throughout production.</p><p>
</p><p style="text-align:center"><strong>Raw Material Volatility Creates Supply Chain Challenges</strong></p><p>
</p><p>Fluctuations in aluminum and hydrochloric acid prices directly impact production costs for aluminum chloride hexahydrate. The aluminum market experienced 28% price volatility between 2021-2023, causing significant margin pressures for manufacturers. Furthermore, energy-intensive production processes make the industry vulnerable to power cost variations. Many producers operate with slim profit margins of 8-12%, leaving limited room to absorb such input cost increases. These economic factors discourage new market entrants and may lead to consolidation among existing suppliers.</p><p>
</p><p style="text-align:center"><strong>Growing Preference for Aluminum-Free Alternatives</strong></p><p>
</p><p>Heightened consumer awareness about potential health concerns associated with aluminum compounds has led to increased demand for alternative antiperspirant actives. While clinical evidence remains inconclusive, market surveys indicate that 32% of consumers actively seek aluminum-free personal care products. This trend has prompted formulators to explore substitutes like potassium alum or botanical astringents, particularly in natural and organic cosmetic lines. Although traditional aluminum-based products still dominate the clinical antiperspirant segment, this shifting preference represents a long-term challenge for market growth.</p><p>
<strong>MARKET CHALLENGES</strong></p><p>
</p><p style="text-align:center"><strong>Environmental and Safety Concerns Pose Operational Hurdles</strong></p><p>
</p><p>Manufacturing aluminum chloride hexahydrate presents several environmental challenges that impact production scalability. The compound's hygroscopic nature requires specialized handling and storage facilities, while wastewater treatment costs can account for up to 18% of operational expenses. Workplace safety regulations mandate extensive protective measures due to the material's corrosive properties. Facilities must invest in advanced ventilation systems, corrosion-resistant equipment, and comprehensive staff training programsâfactors that collectively increase capital expenditure requirements by 30-40% compared to conventional chemical production.</p><p>
</p><p><strong>Other Challenges</strong></p><p>
</p><p><strong>Technological Obsolescence</strong></p><p>
The industry faces pressure to modernize aging production facilities, with approximately 45% of global capacity operating with technology over 15 years old. While newer membrane-based processes offer improved efficiency and yield, the high capital costs of $8-12 million per production line deter upgrades.</p><p>
</p><p><strong>Geopolitical Factors</strong></p><p>
Trade restrictions and export controls on aluminum-related products have created supply uncertainties. Several countries have implemented export tariffs ranging from 5-15% on aluminum compounds, disrupting traditional supply chains and forcing manufacturers to re-evaluate their sourcing strategies.</p><p>
<strong>MARKET OPPORTUNITIES</strong></p><p>
</p><p style="text-align:center"><strong>Emerging Markets Offer Significant Growth Potential</strong></p><p>
</p><p>Developing economies in Asia and Latin America present lucrative opportunities due to expanding healthcare access and growing middle-class populations. The Asia-Pacific pharmaceutical market is projected to grow at 7.8% CAGR through 2030, substantially higher than the global average. Countries with hot, humid climates show particular promise for antiperspirant applications, with Southeast Asia's personal care market expanding at 9.2% annually. Market players can capitalize on these trends through strategic local partnerships and tailored product formulations that address regional preferences and regulatory requirements.</p><p>
</p><p style="text-align:center"><strong>Innovative Drug Delivery Systems Create New Applications</strong></p><p>
</p><p>Advances in transdermal and topical drug delivery technologies are opening new therapeutic applications for aluminum chloride hexahydrate. Researchers are exploring its potential in enhanced formulations for pain management, dermatological conditions, and even vaccine adjuvants. The global transdermal drug delivery system market, projected to reach $125 billion by 2030, offers substantial opportunities for specialty chemical manufacturers. Companies investing in research collaborations with pharmaceutical developers can secure long-term supply agreements and premium pricing for high-purity grades.</p><p>
</p><p style="text-align:center"><strong>Sustainable Production Methods Enhance Competitiveness</strong></p><p>
</p><p>Environmental sustainability has become a key differentiator in the specialty chemicals market. Manufacturers implementing green chemistry principlesâsuch as closed-loop water systems and waste minimization strategiesâcan achieve 15-25% reduction in production costs while meeting stringent environmental standards. The development of energy-efficient crystallization processes and recycling initiatives for byproducts presents opportunities to improve margins and attract environmentally conscious customers. These sustainable practices also help mitigate regulatory risks associated with traditional production methods.</p><p>

</p><p>
<strong>Segment Analysis:</strong></p><p>
<strong>By Type</strong></p><p>
</p><p><strong>Powder Aluminum Chloride Hexahydrate Segment Leads the Market Due to Higher Pharmaceutical Application Compatibility</strong></p><p>
</p><p>The market is segmented based on type into:</p><p>
</p><p>Granule Aluminum Chloride Hexahydrate</p><p>
	</p><p>Subtypes: Industrial-grade, Technical-grade, and others</p><p>Powder Aluminum Chloride Hexahydrate</p><p>Crystal Aluminum Chloride Hexahydrate</p><p>
<strong>By Application</strong></p><p>
</p><p><strong>Pharmaceutical Segment Dominates Due to Extensive Use in Antiperspirants and Astringents</strong></p><p>
</p><p>The market is segmented based on application into:</p><p>
</p><p>Pharmaceutical</p><p>Cosmetics</p><p>Water Treatment</p><p>Others</p><p>
<strong>By Purity Level</strong></p><p>
</p><p><strong>High Purity Grade Segment Holds Major Share for Critical Pharmaceutical Formulations</strong></p><p>
</p><p>Standard Grade</p><p>High Purity Grade (&gt;99%)</p><p>Ultra High Purity Grade</p><p>
<strong>By End User</strong></p><p>
</p><p><strong>Pharmaceutical Manufacturers Are Key Consumers for API Production</strong></p><p>
</p><p>Pharmaceutical Companies</p><p>Cosmetic Manufacturers</p><p>Chemical Formulators</p><p>Research Laboratories</p><p>

</p><p>
<strong>COMPETITIVE LANDSCAPE</strong></p><p>
<strong>Key Industry Players</strong></p><p>
</p><p style="text-align:center"><strong>Established Chemical Giants Compete with Emerging Players in High-Purity Pharma Market</strong></p><p>
</p><p>The global pharma grade aluminum chloride hexahydrate market features a mix of multinational chemical corporations and specialized manufacturers, creating a moderately competitive environment. <strong>BASF</strong> leads this sector through its extensive chemical expertise and vertically integrated production capabilities, controlling approximately 18% of the market share in 2024. The company's pharmaceutical solutions division has been particularly active in developing high-purity formulations for medical applications.</p><p>
</p><p><strong>Honeywell International</strong> and <strong>Kemira</strong> have solidified their positions through strategic acquisitions and technological advancements in purification processes. These companies have successfully expanded their distribution networks across Europe and North America, where pharmaceutical manufacturing standards are most stringent. Meanwhile, Asian producers like <strong>Kanto Denka Kogyo</strong> and <strong>Nippon Light Metal</strong> are gaining traction by offering cost-competitive alternatives without compromising on quality compliance.</p><p>
</p><p>The market has seen increased competition from regional players such as <strong>Gujarat Alkalies and Chemicals</strong> in India and <strong>Aditya Birla Chemicals</strong>, which benefit from local production advantages and government support for pharmaceutical raw material manufacturing. These companies are investing heavily in R&amp;D to meet the growing demand for USP/EP grade materials required in topical medications and antiperspirant formulations.</p><p>
</p><p>Market consolidation has accelerated recently, with active investments in production capacity expansions and quality certifications. The pharmaceutical industry's shift toward premium-grade excipients has compelled manufacturers to enhance their purification technologies and supply chain reliability. Partnerships between chemical producers and pharmaceutical end-users are becoming more common to ensure consistent quality standards across batches.</p><p>
<strong>List of Key Pharma Grade Aluminum Chloride Hexahydrate Producers</strong></p><p>
</p><p>BASF (Germany)</p><p>Honeywell International (U.S.)</p><p>Kemira (Finland)</p><p>DCM Shriram (India)</p><p>Spectrum Chemical (U.S.)</p><p>Anmol Chloro Chem (India)</p><p>Aditya Birla Chemicals (India)</p><p>Gujarat Alkalies and Chemicals (India)</p><p>Kanto Denka Kogyo (Japan)</p><p>Nippon Light Metal (Japan)</p><p>IRO GROUP (China)</p><p>Base Metal Group (China)</p><p>

</p><p>
<strong>PHARMA GRADE ALUMINUM CHLORIDE HEXAHYDRATE MARKET TRENDS</strong></p><p>
<strong>Growing Pharmaceutical Applications Drive Market Expansion</strong></p><p>
</p><p>The pharmaceutical industry's increasing adoption of aluminum chloride hexahydrate as a key excipient and active pharmaceutical ingredient (API) is significantly boosting market growth. With the global pharmaceutical market projected to exceed 1.47 trillion dollars in 2022 and maintaining a steady 5% CAGR, demand for high-purity pharmaceutical ingredients like aluminum chloride hexahydrate continues to rise. Its effectiveness as an antiperspirant and astringent in dermatological treatments has made it indispensable for conditions like hyperhidrosis and minor bleeding control. Additionally, recent studies highlighting its antimicrobial properties have opened new therapeutic applications in wound care and antiseptic formulations. Manufacturers are responding by increasing production capacities, with several leading chemical companies expanding their pharma-grade production lines by 15-20% annually to meet this growing demand.</p><p>
<strong>Other Trends</strong></p><p>
</p><p><strong>Cosmetic Industry Adoption Accelerates</strong></p><p>
</p><p>The personal care sector is emerging as a significant consumer of pharma-grade aluminum chloride hexahydrate due to stringent quality requirements in premium cosmetic formulations. While traditional antiperspirants dominate usage, innovative applications in skin toners and acne treatments are gaining traction. This shift correlates with the global cosmetics market growth, which is expanding at approximately 4.5% annually. The compound's purity specifications (typically 99.9% for pharma-grade) make it particularly valuable for brands positioning themselves in the dermatologist-recommended skincare segment. However, regulatory scrutiny on aluminum-based ingredients in some regions has prompted manufacturers to invest in research demonstrating product safety and efficacy.</p><p>
<strong>Regional Production Shifts and Supply Chain Optimization</strong></p><p>
</p><p>Market dynamics are being reshaped by strategic geographical repositioning of manufacturing facilities to optimize costs and ensure supply chain resilience. Asia-Pacific has emerged as a production hub, accounting for nearly 40% of global capacity, driven by lower production costs and proximity to raw material sources. Meanwhile, North American and European manufacturers are focusing on premium, high-margin pharmaceutical applications while implementing advanced purification technologies to differentiate their products. The recent global supply chain disruptions have accelerated investments in regional stockpiling strategies, with major pharmaceutical companies now maintaining 25-30% higher inventory levels of critical ingredients like aluminum chloride hexahydrate compared to pre-2020 levels.</p><p>
</p><p>
<strong>Regional Analysis: Pharma Grade Aluminum Chloride Hexahydrate Market</strong></p><p>
</p><p><strong>North America</strong></p><p>
The North American market for Pharma Grade Aluminum Chloride Hexahydrate is characterized by stringent regulatory oversight from agencies like the FDA and a robust pharmaceutical manufacturing sector. The U.S. accounts for over 80% of regional demand, driven by its advanced pharmaceutical formulations and established dermatological treatment protocols. However, growth faces challenges due to increasing scrutiny over aluminum-based compounds in antiperspirants, prompting manufacturers to invest in purity enhancement technologies. Canada's market benefits from healthcare system expansions, while Mexico presents emerging opportunities through contract manufacturing growth for export markets. Regulatory compliance remains the primary driver of product specification standards across the region.</p><p>
</p><p><strong>Europe</strong></p><p>
Europe maintains the world's most rigorous quality standards for pharmaceutical ingredients, with the European Pharmacopoeia setting benchmark specifications for aluminum chloride hexahydrate. Germany and France lead in consumption, supported by their strong dermatological pharmaceutical sectors and research into aluminum salt applications. The EU's REACH regulations have compelled manufacturers to enhance production processes to eliminate impurities, adding cost pressures. Recent developments include increasing adoption in wound care formulations and hemostatic products. While Western Europe shows mature, steady demand, Eastern European markets are registering above-average growth due to pharmaceutical industry modernization and improving healthcare access.</p><p>
</p><p><strong>Asia-Pacific</strong></p><p>
As the fastest-growing regional market, Asia-Pacific benefits from expanding pharmaceutical manufacturing capabilities and lower production costs. China dominates both production and consumption, with its pharma grade aluminum chloride hexahydrate output growing at 7% annually. India's market is fueled by its thriving generic drug industry and increasing exports of active pharmaceutical ingredients. Japan and South Korea maintain stringent quality requirements that local manufacturers increasingly meet. The region faces challenges with quality consistency, but major suppliers are achieving international certifications to access premium markets. Southeast Asian countries are emerging as important consumers due to growing over-the-counter pharmaceutical sectors and cosmetic applications.</p><p>
</p><p><strong>South America</strong></p><p>
Market growth in South America remains constrained by economic volatility but shows potential in Brazil and Argentina's developing pharmaceutical sectors. Brazil accounts for approximately 60% of regional demand, primarily for antiperspirant formulations. The lack of regional production capability means most supply is imported, subjecting the market to currency fluctuation risks. Recent regulatory harmonization efforts among Mercosur countries are gradually improving quality standards. While cosmetic applications drive most current consumption, pharmaceutical use is expected to grow as local drug manufacturers expand their product portfolios. Infrastructure limitations and bureaucratic hurdles continue to challenge market expansion.</p><p>
</p><p><strong>Middle East &amp; Africa</strong></p><p>
This region represents an emerging but fragmented market where pharmaceutical-grade material competes with industrial-grade substitutes. The GCC countries, particularly Saudi Arabia and UAE, show the most advanced demand patterns due to their developed healthcare infrastructure and regulatory systems. South Africa serves as the main access point for Sub-Saharan markets, though informal sector dominance limits premium product penetration. Recent initiatives to build regional pharmaceutical manufacturing capacity in North Africa present new opportunities. While current consumption remains low compared to other regions, projected healthcare expenditure growth suggests significant potential, especially for wound care and dermatological applications.</p><p>
</p><p>
<strong>Report Scope</strong></p><p>
</p><p>This report presents a comprehensive analysis of the global and regional markets for Pharma Grade Aluminum Chloride Hexahydrate, covering the period from 2024 to 2032. It includes detailed insights into the current market status and outlook across various regions and countries, with specific focus on:</p><p>
</p><p><strong>Sales, sales volume, and revenue forecasts</strong></p><p><strong>Detailed segmentation by type and application</strong></p><p>
</p><p>In addition, the report offers in-depth profiles of key industry players, including:</p><p>
</p><p>Company profiles</p><p>Product specifications</p><p>Production capacity and sales</p><p>Revenue, pricing, gross margins</p><p>Sales performance</p><p>
</p><p>It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.</p><p>
</p><p>As part of this research, we surveyed Pharma Grade Aluminum Chloride Hexahydrate manufacturers, suppliers, and industry experts. The survey covered various aspects, including:</p><p>
</p><p>Revenue and demand trends</p><p>Product types and recent developments</p><p>Strategic plans and market drivers</p><p>Industry challenges, obstacles, and potential risks</p><p>
<strong>FREQUENTLY ASKED QUESTIONS:</strong></p><p>
<strong>What is the current market size of Global Pharma Grade Aluminum Chloride Hexahydrate Market?</strong></p><p>
</p><p><strong>-&gt;</strong> The global Pharma Grade Aluminum Chloride Hexahydrate market was valued at <strong>USD 167 million in 2024</strong> and is projected to reach <strong>USD 241 million by 2032</strong>, growing at a <strong>CAGR of 5.2%</strong> from 2025 to 2032.</p><p>
<strong>Which key companies operate in Global Pharma Grade Aluminum Chloride Hexahydrate Market?</strong></p><p>
</p><p><strong>-&gt; Key players</strong> include <strong>Anmol Chloro Chem, DCM Shriram, Spectrum Chemical, BASF, Aditya Birla Chemicals, Kemira, and Honeywell International</strong>, among others.</p><p>
<strong>What are the key growth drivers?</strong></p><p>
</p><p>-&gt; Key growth drivers include <strong>increasing demand for pharmaceutical applications, rising prevalence of hyperhidrosis, and growing use in cosmetics for antiperspirant formulations</strong>.</p><p>
<strong>Which region dominates the market?</strong></p><p>
</p><p><strong>-&gt; North America</strong> holds the largest market share, while <strong>Asia-Pacific</strong> is expected to witness the highest growth rate during the forecast period.</p><p>
<strong>What are the emerging trends?</strong></p><p>
</p><p>-&gt; Emerging trends include <strong>development of advanced formulations, increasing R&amp;D investments, and expansion of pharmaceutical manufacturing capabilities in emerging economies</strong>.</p><p>
</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/296633/pharma-grade-aluminum-chloride-hexahydrate-market">
            https://www.24chemicalresearch.com/reports/296633/pharma-grade-aluminum-chloride-hexahydrate-market</a></b></div><br>
            <b>Table of Content:</b><p>1 Introduction to Research & Analysis Reports<br />
 1.1 Pharma Grade Aluminum Chloride Hexahydrate Market Definition<br />
 1.2 Market Segments<br />
 1.2.1 Segment by Type<br />
 1.2.2 Segment by Application<br />
 1.3 Global Pharma Grade Aluminum Chloride Hexahydrate Market Overview<br />
 1.4 Features & Benefits of This Report<br />
 1.5 Methodology & Sources of Information<br />
 1.5.1 Research Methodology<br />
 1.5.2 Research Process<br />
 1.5.3 Base Year<br />
 1.5.4 Report Assumptions & Caveats<br />
2 Global Pharma Grade Aluminum Chloride Hexahydrate Overall Market Size<br />
 2.1 Global Pharma Grade Aluminum Chloride Hexahydrate Market Size: 2024 VS 2032<br />
 2.2 Global Pharma Grade Aluminum Chloride Hexahydrate Market Size, Prospects & Forecasts: 2020-2032<br />
 2.3 Global Pharma Grade Aluminum Chloride Hexahydrate Sales: 2020-2032<br />
3 Company Landscape<br />
 3.1 Top Pharma Grade Aluminum Chloride Hexahydrate Players in Global Market<br />
 3.2 Top Global Pharma Grade Aluminum Chloride Hexahydrate Companies Ranked by Revenue<br />
 3.3 Global Pharma Grade Aluminum Chloride Hexahydrate Revenue by Companies<br />
 3.4 Global Pharma Grade Aluminum Chloride Hexahydrate Sales by Companies<br />
 3.5 Global Pharma Grade Aluminum Chloride Hexahydrate Price by Manufacturer (2020-2025)<br />
 3.6 Top 3 and Top 5 Pharma Grade Aluminum Chloride Hexahydrate Companies in Global Market, by Revenue in 2024<br />
 3.7 Global Manufacturers Pharma Grade Aluminum Chloride Hexahydrate Product Type<br />
 3.8 Tier 1, Tier 2, and Tier 3 Pharma Grade Aluminum Chloride Hexahydrate Players in Global Market<br />
 3.8.1 List of</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/296633/pharma-grade-aluminum-chloride-hexahydrate-market">
            https://www.24chemicalresearch.com/reports/296633/pharma-grade-aluminum-chloride-hexahydrate-market</a></b></div><br>

<b>CONTACT US:</b><br>
            203A, City Vista, Fountain Road, Kharadi, Pune, India - 411014<br>
            International: +1(332) 2424 294<br>
            Asia: +91 9169162030 <br><br>
            Follow Us On LinkedIn: <a href="https://www.linkedin.com/company/24chemicalresearch/">24ChemicalResearch LinkedIn</a>